ArticleThe journal of international advanced otology2022
Screening of SLC26A4 Gene Hotspots in 2673 Patients Associated with Sensorineural Hearing Loss in Northwestern China.
Article in The journal of international advanced otology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to investigate the incidence of the hotspot mutations c.919-2A>G and c.2168A>G in SLC26A4 in the northwestern Chinese population.
methodsA total of 2673 unrelated patients were recruited from northwestern China, and clinical information was obtained from all patients. Peripheral blood samples were acquired to detect the genotype of each patient by direct sequencing. Statistical analysis was conducted with Statistical Package for the Social Sciences 19.0 software.
resultsOverall, 118 patients (4.4%) were identified with biallelic mutations, including 84 (3.14%) homozygotes and 34 (1.27%) compound heterozygotes. Moreover, significant differences between Han and Uighur were identified regarding the frequencies of c.919-2A>G homozygous and biallelic mutations.
conclusionThis model for the rapid screening of hotspot mutations can identify the molecular cause for 4.4% of patients with severe to profound sensorineural hearing loss in northwestern China, and there may be distinctive hotspot mutations in different ethnic populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.